---
category: news
title: "Kiromic BioPharma Reports First Quarter 2022 Financial Results and Recent Corporate Highlights"
excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) and data mining platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology,"
publishedDateTime: 2022-05-13T12:08:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-health-houston-artificial-intelligence-30ce6c45ac424dae9652f7c7d06dac34"
webUrl: "https://apnews.com/press-release/business-wire/technology-health-houston-artificial-intelligence-30ce6c45ac424dae9652f7c7d06dac34"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

secured: "TWgebl2dX7eUEegFSckirVzUGFWJtW5Xpo1RJkpXUC7o4YgBJsLqUoTeItT4tkwX735evbm74EZaYV9Fijzxp8FAuNKvEieWYqWEnymZjEA/PQSTLabT7PgAQRouMS5baOvZkeS4HmSrUeX40fpNCdAb2AtumFfPYaXlFzPSbESr2FRrQt/1VQUGKFUdc4sUEReYMZFe465C5ObqbIHqVVB7c76oX8JmvQdUw+9VdudOv4H5SesOpVw7x+UfKDbJFzvgWOIEA2sHaiabyj1wVcruRjNtP0OQBgHLkq6veVmLOcjDNnjWw00RYqQoqdRmsnnuZWPDCxt3vPVwcp4A5dbjdi5td7MpNmTj2TGVv7s=;P5y9dwGUPrOZHDdMXsjM8g=="
---

